Delivery Order SPE2DB24D1205-SPE2DB24FCSTD
Award Date
7/12/24
Potential Completion Date
8/2/24
Potential Value
$13K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of ZEPOSIA 0.92 MG CAPSULE 30S, a pharmaceutical product. The award has a ceiling value of $13,862.79 and a final completion date of July 17, 2025. This delivery order is associated with Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of the prescription medication ZEPOSIA 0.92 MG CAPSULE 30S. The contract is a firm-fixed price delivery order with a ceiling value of $4,466.57 and an ultimate completion date of October 17, 2024. AmerisourceBergen, a major pharmaceutical distributor, will provide the medication to support military treatment facilities and other government healthcare programs. This order is part...
This is a federal delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corporation for the supply of ZEPOSIA 0.92 MG CAPSULE 30S, a pharmaceutical product. The contract is a firm fixed-price delivery order with a ceiling value of $13,399.71 and an ultimate completion date of September 25, 2024. Amerisourcebergen, a major pharmaceutical distributor, has been awarded this contract as part of its ongoing efforts to provide...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of the medication ZEPOSIA 0.92 MG CAPSULE 30S. The contract has a firm fixed price of $9,241.86 and a completion date of July 15, 2025. It is not a set-aside contract, indicating open competition. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of ZEPOSIA 0.92 MG CAPSULE 30S. The contract has a ceiling value of $13,399.71 and an ultimate completion date of October 11, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for...
This is a delivery order contract awarded by the Defense Logistics Agency Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the supply of ZEPOSIA 0.92 MG CAPSULE 30S, a pharmaceutical product. The firm fixed price contract has a potential value of $13,399.71 and a period of performance through March 20, 2024. Amerisourcebergen Drug Corp is the prime contractor, and no set-aside designation was used for this award. This...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of ZEPOSIA 0.92 MG CAPSULE 30S. The contract has a ceiling value of $13,862.79 and a performance period through May 28, 2025. It is a firm-fixed-price contract with no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp Corporate Office Division, a major pharmaceutical distributor, for the supply of ZEPOSIA 0.92 MG CAPSULE 30S. The contract has a firm fixed price of $4,466.57 and a completion date of October 15, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for delivering...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of ZEPOSIA 0.92 MG CAPSULE 30S. The contract has a ceiling value of $14,441.87 and is a Firm Fixed Price arrangement with a completion date of June 2, 2023. The contract was awarded on May 11, 2023 and does not have a set-aside designation, indicating open competition. Amerisourcebergen is a for-profit organization registered in the System...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the pharmaceutical distribution company Amerisourcebergen Corporation. The order, valued at $13,399.71, is for the supply of ZEPOSIA 0.92 MG CAPSULE 30S, a pharmaceutical product. The delivery order falls under an indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, which serves as the primary contract vehicle...